| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Cysteine protease ATG4B |
|---|
| Ligand | BDBM77907 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Dose response confirmation of the uHTS fluorescent assay for identification of inhibitors of ATG4B. |
|---|
| IC50 | 3350±n/a nM |
|---|
| Citation |  PubChem, PC Dose response confirmation of the uHTS fluorescent assay for identification of inhibitors of ATG4B. PubChem Bioassay(2011)[AID] |
|---|
| More Info.: | Get all data from this article, Solution Info, Assay Method |
|---|
| |
| Cysteine protease ATG4B |
|---|
| Name: | Cysteine protease ATG4B |
|---|
| Synonyms: | APG4B | ATG4B | ATG4B_HUMAN | AUTL1 | KIAA0943 | cysteine protease ATG4B isoform a | hck |
|---|
| Type: | Enzyme Catalytic Domain |
|---|
| Mol. Mass.: | 44279.79 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | gi_47132611 |
|---|
| Residue: | 393 |
|---|
| Sequence: | MDAATLTYDTLRFAEFEDFPETSEPVWILGRKYSIFTEKDEILSDVASRLWFTYRKNFPA
IGGTGPTSDTGWGCMLRCGQMIFAQALVCRHLGRDWRWTQRKRQPDSYFSVLNAFIDRKD
SYYSIHQIAQMGVGEGKSIGQWYGPNTVAQVLKKLAVFDTWSSLAVHIAMDNTVVMEEIR
RLCRTSVPCAGATAFPADSDRHCNGFPAGAEVTNRPSPWRPLVLLIPLRLGLTDINEAYV
ETLKHCFMMPQSLGVIGGKPNSAHYFIGYVGEELIYLDPHTTQPAVEPTDGCFIPDESFH
CQHPPCRMSIAELDPSIAVGFFCKTEDDFNDWCQQVKKLSLLGGALPMFELVELQPSHLA
CPDVLNLSLDSSDVERLERFFDSEDEDFEILSL
|
|
|
|---|
| BDBM77907 |
|---|
| n/a |
|---|
| Name | BDBM77907 |
|---|
| Synonyms: | MLS001224379 | N-[(6-chloranyl-4-oxidanylidene-chromen-3-yl)methylideneamino]-3-methoxy-4-oxidanyl-benzamide | N-[(6-chloro-4-keto-chromen-3-yl)methyleneamino]-4-hydroxy-3-methoxy-benzamide | N-[(6-chloro-4-oxo-1-benzopyran-3-yl)methylideneamino]-4-hydroxy-3-methoxybenzamide | N-[(6-chloro-4-oxochromen-3-yl)methylideneamino]-4-hydroxy-3-methoxybenzamide | SMR000678837 | cid_24818506 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C18H13ClN2O5 |
|---|
| Mol. Mass. | 372.759 |
|---|
| SMILES | COc1cc(ccc1O)C(=O)NN=Cc1coc2ccc(Cl)cc2c1=O |
|---|
| Structure | 
|
|---|
Search and Browse
